Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study

Xiaodong Guan; Haishaerjiang Wushouer; Mingchun Yang; Sheng Han; Luwen Shi; Dennis Ross-Degnan; Anita Katharina Wagner

doi:10.1136/bmjopen-2019-031658

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Log out
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Agence Bibliographique de l Enseignement Superieur (ABES)

Citation Tools

PDF

XML

Health policy

Original research

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Guan X, Wushouer H, Yang M, et al

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study

BMJ Open 2019;9:e031658. doi: 10.1136/bmjopen-2019-031658

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password